updated Tue May 11, 2021
The Food and Drug Administration (FDA) on Monday gave the green light for the Pfizer-BioNTech coronavirus vaccine to be used in adolescents 12 to 15 years old, a move that will make millions more people eligible for a vaccine.
The highly anticipated decision is a key step toward ensuring middle and high schools can operate for full in-person learning in the fall — and a major boon to parents concerned about the safety of summer activities.
Read more: https://thehill.com/policy/healthcare/552704-fda-authorizes-pfizer-vaccine-for-adolescents